Sanofi (SAN) News Today €104.12 +0.54 (+0.52%) As of 02/21/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSustainability All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Sanofi treatment of autoimmune hemolytic anemia granted orphan statusFebruary 20 at 12:55 PM | markets.businessinsider.comSanofi moves closer to selling controlling stake in $17bn-valued OpellaFebruary 19 at 12:46 PM | finance.yahoo.comRegeneron, Sanofi Get Speedy FDA Review of Dupixent in Bullous PemphigoidFebruary 18, 2025 | marketwatch.comFDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoidFebruary 18, 2025 | msn.comBanks on the Hook for Sanofi Buyout Face Agonizing Wait to SellFebruary 14, 2025 | finance.yahoo.comJ&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ resultsFebruary 13, 2025 | msn.comSanofi: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyFebruary 13, 2025 | finanznachrichten.deSanofi: Review Determined Vaccine Candidate for Extraintestinal Pathogenic E. Coli Not Sufficiently EffectiveFebruary 13, 2025 | marketwatch.comSanofi Ends Trial for E. Coli Shot and Takes a $250 Million HitFebruary 13, 2025 | bloomberg.comSanofi (SNY): Among the Best International Dividend Stocks to Buy NowFebruary 12, 2025 | msn.comSanofi is transferring its global expertise in insulin production to Saudi Arabia, aligning with Vision 2030 programFebruary 11, 2025 | msn.comSanofi: Execution of a share buyback agreement for up to €2 billionFebruary 7, 2025 | finanznachrichten.deSanofi To Repurchase EUR 2 Bln Worth Of SharesFebruary 7, 2025 | markets.businessinsider.comSanofi’s Sarclisa combo approved in China for multiple myelomaFebruary 3, 2025 | finance.yahoo.comL'ORÉAL: Agreement Between L'Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L'OréalFebruary 3, 2025 | finanznachrichten.deAgreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’OréalFebruary 3, 2025 | finance.yahoo.comSanofi Announces Buy Back Of Shares From L'Oréal - Quick FactsFebruary 3, 2025 | markets.businessinsider.comL’Oreal Sells €3 Billion of Sanofi Stock to DrugmakerFebruary 3, 2025 | bloomberg.comSanofi targets mid to high single-digit sales growth in 2025 with €5B share buyback planFebruary 1, 2025 | seekingalpha.comSanofi reports Q4 2024 increase in net income to $916mFebruary 1, 2025 | msn.comSanofi: Positioned for Strong Growth with Conservative Guidance and Strategic InitiativesJanuary 31, 2025 | markets.businessinsider.comSanofi upgraded to Hold at Deutsche Bank after ‘solid’ Q4 reportJanuary 30, 2025 | markets.businessinsider.comSanofi Expects Strong Earnings Growth This Year, Plans $5.2 Billion BuybackJanuary 30, 2025 | msn.comSanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025January 30, 2025 | finanznachrichten.deSanofi Plans €5 Billion Buyback, Sees Higher Profit GrowthJanuary 30, 2025 | finance.yahoo.comSanofi plans share buybacks, signals more deals post Opella saleJanuary 30, 2025 | msn.comSanofi’s Promising Future: Buy Rating Backed by Strategic Moves and Strong PipelineJanuary 28, 2025 | markets.businessinsider.comSanofi Expected to Report Lower Sales, Profit; Size of Buyback in Focus -- Earnings PreviewJanuary 28, 2025 | marketwatch.comNovo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, SanofiJanuary 27, 2025 | msn.comJ.P. Morgan Sticks to Their Hold Rating for Sanofi (SNYNF)January 24, 2025 | markets.businessinsider.com'The next battleground': Sanofi exploring opportunities in second generation obesity drugsJanuary 23, 2025 | msn.comSanofi Announces Expanded Marketing Authorization For Sarclisa In The EU - Quick FactsJanuary 22, 2025 | markets.businessinsider.comSanofi’s Growth Prospects and Undervalued Position Highlighted by Analyst Graham ParryJanuary 21, 2025 | markets.businessinsider.comSanofi's Opella: FDA Lifts Clinical Hold On OTC Cialis TrialJanuary 21, 2025 | markets.businessinsider.comAI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO saysJanuary 21, 2025 | msn.comSK bioscience and Sanofi’s GBP410 vaccine enters global Phase III trialsJanuary 20, 2025 | finance.yahoo.comSanofi to increase competition in atopic dermatitis market after Dupixent successJanuary 16, 2025 | finance.yahoo.comSanofi: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myelomaJanuary 13, 2025 | finanznachrichten.deScribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with SanofiJanuary 13, 2025 | finance.yahoo.com6SNY : Price Over Earnings Overview: SanofiJanuary 10, 2025 | benzinga.comSanofi reports positive results for subcutaneous SarclisaJanuary 9, 2025 | msn.comHow Formula 1 engineers turbocharged a $200b public companyJanuary 8, 2025 | afr.comAlloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic™ Antisense Platform with SanofiJanuary 7, 2025 | finance.yahoo.comDrugmakers to raise US prices on over 250 medicines starting Jan. 1January 1, 2025 | usatoday.comA Look Into Sanofi Inc's Price Over EarningsDecember 25, 2024 | benzinga.comCytokinetics' potential blockbuster heart drug flips to new partner in ChinaDecember 23, 2024 | bizjournals.comSK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccinesDecember 23, 2024 | finance.yahoo.comSanofi: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccinesDecember 23, 2024 | finanznachrichten.deSanofi To Expand Collaboration With SK Bioscience For Next-generation Pneumococcal VaccinesDecember 23, 2024 | markets.businessinsider.comSanofi and Teva’s duvakitug meets primary endpoints in Phase IIb trialDecember 18, 2024 | msn.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address SAN Media Mentions By Week SAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAN News Sentiment▼0.290.60▲Average Medical News Sentiment SAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAN Articles This Week▼45▲SAN Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Compagnie Générale des Établissements Michelin Société en commandite par actions News Today Deutsche Bank Aktiengesellschaft News Today Bayer Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Genfit News Today Sartorius Stedim Biotech News Today Siemens Healthineers News Today Merck KGaA News Today Fresenius Medical Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:SAN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAN Stock Alerts